Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Philippe Taupin. (2011) Antibodies against CD20 (rituximab) for treating multiple sclerosis: US20100233121. Expert Opinion on Therapeutic Patents 21:1, pages 111-114.
Read now
Read now
Takae Shizusawa, Hirohiko Shibayama, Shinsuke Murata, Yuri Saitoh, Yuna Sugimoto, Itaru Matsumura, Hiroyasu Ogawa, Haruo Sugiyama, Shirou Fukuhara, Masayuki Hino, Akihisa Kanamaru, Amane Yamauchi, Katsuyuki Aozasa & Yuzuru Kanakura. (2008) The expression of anamorsin in diffuse large B cell lymphoma: Possible prognostic biomarker for low IPI patients. Leukemia & Lymphoma 49:1, pages 113-121.
Read now
Read now
Articles from other publishers (31)
Sae-Bom Yoon, Hyowon Hong, Hee-Jong Lim, Ji Hye Choi, Yoon Pyo Choi, Seong Wook Seo, Hyuk Woo Lee, Chong Hak Chae, Woo-Kyu Park, Hyun Young Kim, Daeyoung Jeong, Tran Quang De, Chang-Seon Myung & Heeyeong Cho. (2023) A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway. Acta Pharmaceutica Sinica B 13:3, pages 1093-1109.
Crossref
Crossref
Jing Yang, Ellen L. Weisberg, Shuang Qi, Wei Ni, Husheng Mei, Zuowei Wang, Chengcheng Meng, Shengzhe Zhang, Mingqi Hou, Ziping Qi, Aoli Wang, Yunyun Jiang, Zongru Jiang, Tao Huang, Qingwang Liu, Robert S. Magin, Laura Doherty, Wenchao Wang, Jing Liu, Sara J. Buhrlage, Qingsong Liu & James D. Griffin. (2022) Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2. Leukemia 36:4, pages 1048-1057.
Crossref
Crossref
Tahera Alnassfan, Megan J. Cox‐Pridmore, Azzam Taktak & Kathleen J Till. (2021) Mantle cell lymphoma treatment options for elderly/unfit patients: A systematic review. eJHaem 3:1, pages 276-290.
Crossref
Crossref
Caroline M. Bateman, Alison Kesson, Madeleine Powys, Melanie Wong & Emily Blyth. (2021) Cytomegalovirus Infections in Children with Primary and Secondary Immune Deficiencies. Viruses 13:10, pages 2001.
Crossref
Crossref
Mohamed Bikhet, Hayato Iwase, Takayuki Yamamoto, Abhijit Jagdale, Jeremy B. Foote, Mohamed Ezzelarab, Douglas J. Anderson, Jayme E. Locke, Devin E. Eckhoff, Hidetaka Hara & David K.C. Cooper. (2021) What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?. Transplantation 105:6, pages 1143-1155.
Crossref
Crossref
Jaleh Varshosaz, Saeedeh Fardshouraki, Mina Mirian, Leila Safaeian, Setareh Jandaghian & Somayeh Taymouri. (2020) Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity. Anti-Cancer Agents in Medicinal Chemistry 20:16, pages 1966-1980.
Crossref
Crossref
Yunfei Shi, Lijuan Deng, Yuqin Song, Dongmei Lin, Yumei Lai, LiXin Zhou, Lei Yang & Xianghong Li. (2018) CD3+/CD8+ T-cell density and tumoral PD-L1 predict survival irrespective of rituximab treatment in Chinese diffuse large B-cell lymphoma patients. International Journal of Hematology 108:3, pages 254-266.
Crossref
Crossref
Marta Pillon, Lara Mussolin, Elisa Carraro, Valentino Conter, Maurizio Aricò, Luciana Vinti, Alberto Garaventa, Matilde Piglione, Salvatore Buffardi, Alessandra Sala, Nicola Santoro, Luca Lo Nigro, Rossella Mura, Annalisa Tondo, Fiorina Casale, Piero Farruggia, Paolo Pierani, Simone Cesaro, Emanuele S. G. d'Amore & Giuseppe Basso. (2016) Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol. British Journal of Haematology 175:3, pages 467-475.
Crossref
Crossref
Eusebio S. Pires, Ryan S. D’Souza, Marisa A. Needham, Austin K. Herr, Amir A. Jazaeri, Hui Li, Mark H. Stoler, Kiley L. Anderson-Knapp, Theodore Thomas, Arabinda Mandal, Alain Gougeon, Charles J. Flickinger, David E. Bruns, Brian A. Pollok & John C. Herr. (2015) Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors. Oncotarget 6:30, pages 30194-30211.
Crossref
Crossref
Michael Sandherr, Marcus Hentrich, Marie von Lilienfeld-Toal, Gero Massenkeil, Silke Neumann, Olaf Penack, Lena Biehl & Oliver A. Cornely. (2015) Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Annals of Hematology 94:9, pages 1441-1450.
Crossref
Crossref
Sujatha Gomathinayagam, Drake Laface, Nga Rewa Houston-Cummings, Ruban Mangadu, Renee Moore, Ishaan Shandil, Nathan Sharkey, Huijuan Li, Terrance A. Stadheim & Dongxing Zha. (2015) In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris. Journal of Biotechnology 208, pages 13-21.
Crossref
Crossref
Zeinab H. El-badawi, Amal N.E. Ahmed, Medhat M. Ali & Abd-El-Rahman H. Khalifa. (2012) Correlation of CD74 expression with the Ki-67-labeling index and CD138 in multiple myeloma. Egyptian Journal of Pathology 32:2, pages 198-203.
Crossref
Crossref
Marta Carlesimo, Diego Orsini, Alessanrdra Narcisi, Claudia Abruzzese, Giorgia Cortesi, Gabriella De Marco & Alfredo Rossi. (2012) A Case of Cutaneous Large B-Cell Lymphoma of the Legs Appearing as Chronic Venous Ulceration. Hematology Reports 4:2, pages e6.
Crossref
Crossref
Anton Yuryev. 2011. Systems Biology in Drug Discovery and Development. Systems Biology in Drug Discovery and Development
287
302
.
Simone Boehrer, Petra Schroeder, Tina Mueller, Judith Atz & Kai Uwe Chow. (2011) Cytotoxic effects of the trifunctional bispecific antibody FBTA05 in ex-vivo cells of chronic lymphocytic leukaemia depend on immune-mediated mechanism. Anti-Cancer Drugs 22:6, pages 519-530.
Crossref
Crossref
Barbara Zehnbauer & Mona Nasser. 2011. Hematopathology. Hematopathology
293
323
.
Richard J. O’Reilly, Tao Dao, Guenther Koehne, David Scheinberg & Ekaterina Doubrovina. (2010) Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation. Seminars in Immunology 22:3, pages 162-172.
Crossref
Crossref
Amani Mankaï, Virginie Buhé, Mariam Hammadi, Pierre Youinou, Ibtissem Ghedira, Christian Berthou & Anne Bordron. (2009) Improvement of Rituximab Efficiency in Chronic Lymphocytic Leukemia by CpG-Mediated Upregulation of CD20 Expression Independently of PU.1. Annals of the New York Academy of Sciences 1173:1, pages 721-728.
Crossref
Crossref
Michael Stanglmaier, Margot Faltin, Peter Ruf, Annette Bodenhausen, Petra Schröder & Horst Lindhofer. (2008) Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti‐CD20 × anti‐CD3), mediates efficient killing of B‐cell lymphoma cells even with very low CD20 expression levels. International Journal of Cancer 123:5, pages 1181-1189.
Crossref
Crossref
Eric D. Hsi, Roxanne Steinle, Balaji Balasa, Susann Szmania, Aparna Draksharapu, Benny P. Shum, Mahrukh Huseni, David Powers, Amulya Nanisetti, Yin Zhang, Audie G. Rice, Anne van Abbema, Melanie Wong, Gao Liu, Fenghuang Zhan, Myles Dillon, Shihao Chen, Susan Rhodes, Franklin Fuh, Naoya Tsurushita, Shankar Kumar, Vladimir Vexler, John D. ShaughnessyJr.Jr., Bart Barlogie, Frits van Rhee, Mohamad Hussein, Daniel E.H. Afar & Marna B. Williams. (2008) CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma. Clinical Cancer Research 14:9, pages 2775-2784.
Crossref
Crossref
Moritz Palmowski, Christian Zechmann, Stefanie Satzl, Soenke Bartling & Peter Hallscheidt. (2007) Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma. Annals of Hematology 87:4, pages 337-338.
Crossref
Crossref
Magdalena Winiarska, Jacek Bil, Ewa Wilczek, Grzegorz M Wilczynski, Malgorzata Lekka, Patrick J Engelberts, Wendy J. M Mackus, Elzbieta Gorska, Lukasz Bojarski, Tomasz Stoklosa, Dominika Nowis, Zuzanna Kurzaj, Marcin Makowski, Eliza Glodkowska, Tadeusz Issat, Piotr Mrowka, Witold Lasek, Anna Dabrowska-Iwanicka, Grzegorz W Basak, Maria Wasik, Krzysztof Warzocha, Maciej Sinski, Zbigniew Gaciong, Marek Jakobisiak, Paul W. H. I Parren & Jakub Golab. (2008) Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20. PLoS Medicine 5:3, pages e64.
Crossref
Crossref
Sabeeha Muneer, Sonia Cunningham & Sundar Jagannath. (2008) 49th Annual Meeting of the American Society of Hematology Atlanta, GA; December 8–11, 2007. Clinical Lymphoma and Myeloma 8:1, pages 13-20.
Crossref
Crossref
Dung Le, Elizabeth M. Jaffee & Dan Laheru. 2008. Pancreatic Cancer. Pancreatic Cancer
683
704
.
Martina Crysandt, Britta Neumann, Marco Das, Vera Engelbertz, Michael Bendel, Oliver Galm, Rainhardt Osieka & Edgar Jost. (2007) Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response. European Journal of Haematology 79:6, pages 546-549.
Crossref
Crossref
Miroslav Dumic, Ivo Radman, Nevena Krnic, Marin Nola, Rajko Kusec, Davor Begovic, Boris Labar & Marko Rados. (2007) Successful Treatment of Diffuse Large B-Cell Non-Hodgkin Lymphoma with Modified CHOP (Cyclophosphamide/Doxorubicin/Vincristine/ Prednisone) Chemotherapy and Rituximab in a Patient with Nijmegen Syndrome. Clinical Lymphoma and Myeloma 7:9, pages 590-593.
Crossref
Crossref
Nicole M. Agostino, Arjumand Ali, Suresh G. Nair & Paul J. Mosca. (2007) Current Immunotherapeutic Strategies in Malignant Melanoma. Surgical Oncology Clinics of North America 16:4, pages 945-973.
Crossref
Crossref
C Arber, A Buser, D Heim, M Weisser, A Tyndall, A Tichelli, J Passweg & A Gratwohl. (2007) Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment. Bone Marrow Transplantation 40:6, pages 597-598.
Crossref
Crossref
R. J. Lock & M. M. Gompels. (2007) C1-inhibitor deficiencies (hereditary angioedema): Where are we with therapies?. Current Allergy and Asthma Reports 7:4, pages 264-269.
Crossref
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref
Crossref
Alexandar TzankovPhilip WentStephan Dirnhofer. (2017)
Prognostic Significance of
in situ
Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
. Biomarker Insights 2, pages 117727190700200.
Crossref
Crossref